Allergan: A Splitting Headache? By: Stocks to Watch October 20, 2017 at 14:19 PM EDT J.P. Morgan's Chris Schott says a sum-of-the-parts analysis shows that Allergan is “highly undervalued." Still, he says it's too early to consider a split. Read More >>